Home > Adult Care: Treatment and Support > Treatment Centers and Clinical Services > Thoracic Cancer Treatment Center > Understanding lung cancer risk in patients with inherited EGFR T790M mutations > Eligibility Survey
Thoracic Cancer Treatment Center
Understanding lung cancer risk in patients with inherited EGFR T790M mutations
The purpose of this study is to understand whether inherited EGFR T790M mutations lead to an increased risk of developing lung cancer. This study will lay the groundwork for identifying strategies to reduce the risk of developing lung cancer when an inherited mutation is present. Because individuals and families carrying inherited T790M mutations may not be able to travel to Dana-Farber, we have set up this online survey so that patients not treated at Dana-Farber Cancer Institute may participate remotely in our research study.
Find out more about this research study
This research study is currently open for the following groups of patients and individuals who may be at risk of carrying an inherited T790M mutation:
- Patients with lung cancer whose tumor has been found to carry an EGFR T790M mutation
For example, your oncologist ordered genetic testing on your lung cancer and the results showed a T790M mutation.
- Individuals with a relative who has been found to carry an inherited EGFR mutation
For example, your sister had lung cancer and had blood testing which showed a T790M mutation in her inherited genes.
- Individuals who have already been found to carry an inherited EGFR mutation
For example, your doctor sent you to a genetic counselor and blood testing was done which found a T790M mutation in your inherited genes.
If you think you may be at risk of carrying an inherited T790M mutation and would like to participate in this study, please complete the form below.
All fields are required.